VERIFIEDMint Markets·21 May 2026positive

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?

AI Summary

·The Nifty Pharma index has risen by approximately 11% in the last month.
·The Nifty Pharma index has outperformed the Nifty 50, which saw a 3.6% decline in the same period.
·Year-to-date, the Nifty Pharma index has gained 9.4%, while the Nifty 50 has fallen by an equal margin.